In-house & bespoke training:
Industry

 

Please note: full product details will be shown on our training portal IPI Academy where you can find out more and book

Animal Health

Sample course outlines include:

  • A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products
  • A Practical Approach to Veterinary Vaccine Development and Registration in the EU

See all 10 course outlines

Biopharma

Sample course outlines include:

  • US FDA - Understanding Key Factors When Working with the FDA

See 1 course outline

Cosmetics

Sample course outlines include:

  • Cosmetovigilance
  • Regulatory Compliance and Safety Standards for Aesthetic Devices

See all 2 course outlines

Medical Devices

Sample course outlines include:

  • A Regulatory Update on the Medical Device and In-Vitro Diagnostic Regulations in the EU and UK
  • Advanced Regulatory Affairs for Medical Devices

See all 58 course outlines

Pharmaceutical

Sample course outlines include:

  • A Practical Guide to Producing and Maintaining the PSMF
  • A Practical Guide to Writing Risk Management Plans (RMPs)

See all 140 course outlines

Training options

All of our course outlines are available:
Ready made for any number of participants or With a programme and presenters customised to your requirements
And in your preferred format, or combination:
Face-to-face training at your location or Webinar/interactive online

Previous attendees said...

“Very good. I was expected to improve my knowledge and get some tips and I did it.”

Manon Schönholzer, Drug Safety officer, CIS Bio international

“It was a very very informative webinar which I certainly will recommend to others”

Nanna Sommer, Clinical Trial Assistant, Minervax ApS

“Objective: to get a better understanding of MDSAP requirements was well met by training. Very well put together and delivered. The presenters came across very knowledgeable and experienced, and valuable insight was shared through group discussions. I really liked the structure and pace of the course, and it was suited to my needs.”

Sukhjit Sidhu, Quality Assurance and Compliance Specialist, Sterimedix Ltd

“Overall very good.”

William Hensler, Principal, Alantra BioPharma

“The overall content was strong and informative and I believe there was a good mix of discussions, workshops and information. I wanted to deepen my understanding of clinical trial monitoring, particularly the common pitfalls and how to manage them effectively and how to best monitor online/off-site. I believe I’ve learned several valuable methods for identifying and evaluating issues when something goes wrong in a clinical study. I found the sections on risk-based monitoring approaches very insightful and applicable to my work. I also gained insights into ensuring patient safety and maintaining data integrity, as well as the principles of risk-based monitoring. The session on root cause analysis was especially valuable, and I plan to implement this approach in my own clinical study. Overall, I feel that I’ve achieved the goals I set out for this course.”

Isabella Åström, Clinical Research Associate, Atos Medical

“The programme was well-structured and informative. The session provided practical guidance on structuring SOPs, using clear and concise language, and tailoring content to the intended audience. The real-world examples and actionable tips were especially valuable, and I now feel more confident in my ability to revise or create SOPs that align with current standards and expectations. The speaker was very knowledgeable and engaging throughout. Her expertise in SOP writing was clear, and she communicated complex ideas in a straightforward and easy-to-understand way. I particularly appreciated the practical examples and real-life scenarios shared, which made the content more relatable and actionable. She also encouraged questions and interaction, creating a welcoming and supportive learning atmosphere. Overall, her delivery significantly enhanced the quality and value of the training. It struck a good balance between theory and actionable advice, which made it easy to understand and apply.

In summary, the webinar was a valuable learning experience that provided useful tools and insights for writing effective SOPs.”

Amalia Neophytou, Trainer Analyst, Remedica Ltd

“Group tasks were good, as the interactive parts put theory into practice. Language, speed, flow, and overall presentation was good and easy to follow. Absolutely worth while as an intro to writing of SOPs.”

Thomas Bidstrup, Clinical Research Specialist, Ambu A/S

“I have accomplished a better understanding of API's after the two day webinar. Very good webinar which covers a good range of content, a little dense, so will need to refer back to it at some stage. Speakers were nice and accommodating. They clearly have a good understanding of the content they are presenting.”

Stephany Banglayan, Research and Development Analyst, Xeolas Pharmaceuticals

“I hoped to achieve a full picture of APIs for my new job and yes I accomplished it. A lot of information..
”

Marie Lucchini, Regulatory affairs Supervisor, Actylis

“Overall, very good. Detailed presentations that were easy to follow.”

Kristen Mandello, Associate Director, Zoetis